Graph Neural Networks for Predicting Drug-Target Interactions in Rare Disease
Rare diseases affect millions of people worldwide, yet the discovery of effective treatments remains hindered by limited biological data, sparse drug–target interaction (DTI) information, and the high cost of experimental validation. Existing computational approaches often struggle to maintain predictive performance un...